These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3625218)

  • 1. Reduction of arginine-vasopressin in the cerebral cortex in Alzheimer type senile dementia.
    Fujiyoshi K; Suga H; Okamoto K; Nakamura S; Kameyama M
    J Neurol Neurosurg Psychiatry; 1987 Jul; 50(7):929-32. PubMed ID: 3625218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neocortical concentrations of neuropeptides in senile dementia of the Alzheimer and Lewy body type: comparison with Parkinson's disease and severity correlations.
    Leake A; Perry EK; Perry RH; Jabeen S; Fairbairn AF; McKeith IG; Ferrier IN
    Biol Psychiatry; 1991 Feb; 29(4):357-64. PubMed ID: 1674664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotransmitters in dementia.
    Nakamura S; Koshimura K; Kato T; Yamao S; Iijima S; Nagata H; Miyata S; Fujiyoshi K; Okamoto K; Suga H
    Clin Ther; 1984; 7 Spec No():18-34. PubMed ID: 6152197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type.
    Chalmers DT; Dewar D; Graham DI; Brooks DN; McCulloch J
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1352-6. PubMed ID: 2154742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senile dementia and Alzheimer's disease: lack of changes of the cortical content of quinolinic acid.
    Moroni F; Lombardi G; Robitaille Y; Etienne P
    Neurobiol Aging; 1986; 7(4):249-53. PubMed ID: 2944022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arginine vasopressin and choline acetyltransferase in brains of patients with Alzheimer type senile dementia.
    Rossor MN; Iversen LL; Mountjoy CQ; Roth M; Hawthorn J; Ang VY; Jenkins JS
    Lancet; 1980 Dec 20-27; 2(8208-8209):1367-8. PubMed ID: 6109178
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type.
    Rossor MN; Emson PC; Mountjoy CQ; Roth M; Iversen LL
    Neurosci Lett; 1980 Dec; 20(3):373-7. PubMed ID: 6108540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No global neocortical nerve cell loss in brains from patients with senile dementia of Alzheimer's type.
    Regeur L; Jensen GB; Pakkenberg H; Evans SM; Pakkenberg B
    Neurobiol Aging; 1994; 15(3):347-52. PubMed ID: 7936059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical substance P-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
    Crystal HA; Davies P
    J Neurochem; 1982 Jun; 38(6):1781-4. PubMed ID: 6176686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic vasopressin and oxytocin mRNA expression in relation to depressive state in Alzheimer's disease: a difference with major depressive disorder.
    Meynen G; Unmehopa UA; Hofman MA; Swaab DF; Hoogendijk WJ
    J Neuroendocrinol; 2009 Aug; 21(8):722-9. PubMed ID: 19500216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Senile dementia and presenile dementia.
    Nakamura S
    Tohoku J Exp Med; 1990 Aug; 161 Suppl():49-60. PubMed ID: 1707190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin in Alzheimer's disease: a study of postmortem brain concentrations.
    Mazurek MF; Beal MF; Bird ED; Martin JB
    Ann Neurol; 1986 Dec; 20(6):665-70. PubMed ID: 3813496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin immunoreactivity is reduced in Parkinson's disease dementia with Alzheimer's changes.
    Beal MF; Mazurek MF; Martin JB
    Brain Res; 1986 Nov; 397(2):386-8. PubMed ID: 3801878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for blood-brain barrier changes in senile dementia of the Alzheimer type (SDAT).
    Wisniewski HM; Kozlowski PB
    Ann N Y Acad Sci; 1982; 396():119-29. PubMed ID: 6185032
    [No Abstract]   [Full Text] [Related]  

  • 15. Cortical atrophy in senile dementia of the Alzheimer type is mainly due to a decrease in cortical length.
    Duyckaerts C; Hauw JJ; Piette F; Rainsard C; Poulain V; Berthaux P; Escourolle R
    Acta Neuropathol; 1985; 66(1):72-4. PubMed ID: 3993335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An experimental study of arginine vasopressin on acute ischemic brain edema in gerbils (1)].
    Liu X
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Aug; 25(4):232-4, 254. PubMed ID: 1478142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A quantitative study of the cerebral cortex in Alzheimer's disease and senile dementia using an automatic image analyzing system.
    Sauer B; Dietl HW; Kretschmann HJ; Mehraein P
    J Hirnforsch; 1986; 27(6):695-702. PubMed ID: 3571965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A comparative study on histopathological findings between Alzheimer's disease and senile dementia of Alzheimer type].
    Nakamura N
    Rinsho Byori; 1996 Mar; 44(3):225-30. PubMed ID: 8857164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An autopsy case of senile dementia with numerous neocortical senile plaques and preserved subcortical nuclei].
    Wakabayashi K; Takahashi H; Ikuta F; Homma Y
    Rinsho Shinkeigaku; 1989 Sep; 29(9):1163-7. PubMed ID: 2598544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of the basal nucleus of Meynert in senile dementia of Alzheimer's type. A preliminary report.
    Turnbull IM; McGeer PL; Beattie L; Calne D; Pate B
    Appl Neurophysiol; 1985; 48(1-6):216-21. PubMed ID: 3915647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.